Wycombe General Hospital

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 2	2026-10-05	NCT06979362
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 2	2026-05-27	NCT06991257
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 2	2026-03-11	NCT06979375
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial	Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, vascular disorder	Active, not recruiting	Phase 3	2026-02-27	NCT05581303

Clinical trials